{"id":27,"date":"2023-04-25T09:32:38","date_gmt":"2023-04-25T09:32:38","guid":{"rendered":"https:\/\/lexitas.com\/?page_id=27"},"modified":"2026-02-18T11:48:17","modified_gmt":"2026-02-18T16:48:17","slug":"home","status":"publish","type":"page","link":"https:\/\/lexitas.com\/","title":{"rendered":"Home"},"content":{"rendered":"\n
\n
<\/div>\n
\n
\n
\n
\n
\n

\n Your Partner for Unmatched Expertise in Ophthalmology Clinical Research <\/h2>\n

Lexitas delivers tailored approaches, rigorous quality standards, and unwavering commitment to operational success.<\/p>\n

\n \n Contact Us \n \n \n \n \n \n \n <\/linearGradient>\n <\/defs>\n<\/svg> <\/a>\n \n Learn about our Services \n \n \n \n \n \n \n <\/linearGradient>\n <\/defs>\n<\/svg> <\/a>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n \"\"\/\n <\/div>\n
\n
\n \"\"\/\n <\/div>\n \"\"\/\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n\n\n
\n
\n
\n
<\/div>\n <\/div>\n
\n
<\/div>\n <\/div>\n
\n
\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n\n
\n
\n
\n
<\/div>\n <\/div>\n
\n
<\/div>\n <\/div>\n
\n
\n

Why work with us<\/h2>\n

Lexitas is a specialized clinical research organization with over 15 years dedicated exclusively to ophthalmology.<\/h1>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n\n
\n
\n \n
\n
\n
\n
<\/div>\n \"\"\/\n
<\/div>\n <\/div>\n <\/div>\n\n
\n
\n
\n
1<\/span><\/div>\n \n

Deep ophthalmology expertise<\/h4>\n \n

Our team of ophthalmologists, optometrists, clinical operations specialists, and imaging experts have more than 475 years of combined experience in ophthalmology and clinical research.<\/p>\n <\/div>\n

\n
2<\/span><\/div>\n \n

Personalized services<\/h4>\n \n

Our operating procedures and systems allow us to tailor our work to meet the specific needs of each protocol, customer, and project. <\/p>\n <\/div>\n

\n
3<\/span><\/div>\n \n

End-to-end expert guidance<\/h4>\n \n

Our extensive capabilities and experience across all ophthalmic subspecialties enable us to guide you through every stage of the development process.<\/p>\n <\/div>\n <\/div>\n\n

\n
\n
\n
1<\/span><\/div>\n\n

Deep ophthalmology expertise<\/h4>\n \n

Our team of ophthalmologists, optometrists, clinical operations specialists, and imaging experts have more than 475 years of combined experience in ophthalmology and clinical research.<\/p>\n <\/div>\n

\n
2<\/span><\/div>\n\n

Personalized services<\/h4>\n \n

Our operating procedures and systems allow us to tailor our work to meet the specific needs of each protocol, customer, and project. <\/p>\n <\/div>\n

\n
3<\/span><\/div>\n\n

End-to-end expert guidance<\/h4>\n \n

Our extensive capabilities and experience across all ophthalmic subspecialties enable us to guide you through every stage of the development process.<\/p>\n <\/div>\n <\/div>\n

<\/div>\n <\/div>\n \n
\n \n Learn How We Can Help \n \n \n \n \n \n \n <\/linearGradient>\n <\/defs>\n<\/svg> <\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

Lexitas is your partner for ophthalmic clinical research at every stage.<\/h3>\n\n\n\n
<\/div>\n\n\n
\n
\n
\n
\n \"\"\/\n

What our clients say<\/h3>\n
\n
\n \"\"\/\n <\/div>\n
\n \"\"\/\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n
\n
\n \"\"\n <\/div>\n
\n
\n
\n
\n
\n
Justin Hanes<\/h6>\n

\n Chief Executive Officer, Novus Vision <\/p>\n <\/div>\n <\/div>\n

\n It has been a pleasure working with Lexitas. Their expertise in ophthalmology, attention to detail, and commitment to timelines made a complex process manageable and collaborative. Their proactive communication and problem-solving approach gave us confidence at every stage, and ultimately helped ensure the study ran smoothly from start to finish. <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Sean McDonald<\/h6>\n

\n Chief Executive Officer, Ocugenix <\/p>\n <\/div>\n <\/div>\n

\n “We chose Lexitas because of their exceptional experience in the ophthalmology field, with established relationships with key opinion leaders and clinical sites. Their expert management of our study will enable us to move ahead with our clinical development plan.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Sonja Krosser<\/h6>\n

\n VP Preclinical & Clinical Development, Novaliq <\/p>\n <\/div>\n <\/div>\n

\n “We value Lexitas as a full-service CRO that shares our passion for ophthalmology and our mission to bring innovative eye care treatments to patients. In our current project, Lexitas exceeded expectations by delivering the last patient-in well ahead of schedule.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
David Esposito<\/h6>\n

\n Chief Executive Officer, ONL Therapeutics <\/p>\n <\/div>\n <\/div>\n

\n “Lexitas was an instrumental partner in our study, delivering CRO services as well as access to their integrated Reading Center. With an exclusive focus on ophthalmology, their team was equipped to provide expert guidance and support throughout the project.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Ben Yerxa<\/h6>\n

\n Chief Executive Officer, Opus Genetics <\/p>\n <\/div>\n <\/div>\n

\n “As a small company, we prefer working with smaller CROs where personal connections matter. It\u2019s about interacting directly with team members and having direct access to the CEO.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Rob Beathard<\/h6>\n

\n Chief Strategy Officer, jCyte <\/p>\n <\/div>\n <\/div>\n

\n “Working with this team has been a great experience thanks to their ‘white glove’ service and collaborative approach. We truly value their operational insights, which have helped us avoid potential issues as we work towards initiating our next trial. Their expertise and attention to detail has ensured a smoother process from the very start of our engagement.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Houman Hemmati, MD, PHD <\/h6>\n

\n Co-founder, Levation Pharma <\/p>\n <\/div>\n <\/div>\n

\n \u201cLexitas isn\u2019t a CRO \u2013 it\u2019s truly a partner committed to the success of each clinical program.\u201d <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Clare Guererro<\/h6>\n

\n Senior Director, Clinical Operations, PYC Therapeutics <\/p>\n <\/div>\n <\/div>\n

\n “We’ve had a wonderful experience working with Lexitas. Their dedication to excellence and seamless collaboration has made them an invaluable partner. Their expertise and commitment to our Quokka trial have consistently delivered outstanding results. We couldn’t ask for a better vendor to support our observational trial and research efforts.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Madhu Cherukury<\/h6>\n

\n Chief Executive Officer, Allgenesis <\/p>\n <\/div>\n <\/div>\n

\n “The Lexitas team has been a pleasure to work with, providing exceptional support throughout our clinical program, and providing an enjoyable collaborative effort in writing the CSR.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Justin Hanes<\/h6>\n

\n Chief Executive Officer, Novus Vision <\/p>\n <\/div>\n <\/div>\n

\n It has been a pleasure working with Lexitas. Their expertise in ophthalmology, attention to detail, and commitment to timelines made a complex process manageable and collaborative. Their proactive communication and problem-solving approach gave us confidence at every stage, and ultimately helped ensure the study ran smoothly from start to finish. <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Sean McDonald<\/h6>\n

\n Chief Executive Officer, Ocugenix <\/p>\n <\/div>\n <\/div>\n

\n “We chose Lexitas because of their exceptional experience in the ophthalmology field, with established relationships with key opinion leaders and clinical sites. Their expert management of our study will enable us to move ahead with our clinical development plan.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Sonja Krosser<\/h6>\n

\n VP Preclinical & Clinical Development, Novaliq <\/p>\n <\/div>\n <\/div>\n

\n “We value Lexitas as a full-service CRO that shares our passion for ophthalmology and our mission to bring innovative eye care treatments to patients. In our current project, Lexitas exceeded expectations by delivering the last patient-in well ahead of schedule.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
David Esposito<\/h6>\n

\n Chief Executive Officer, ONL Therapeutics <\/p>\n <\/div>\n <\/div>\n

\n “Lexitas was an instrumental partner in our study, delivering CRO services as well as access to their integrated Reading Center. With an exclusive focus on ophthalmology, their team was equipped to provide expert guidance and support throughout the project.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Ben Yerxa<\/h6>\n

\n Chief Executive Officer, Opus Genetics <\/p>\n <\/div>\n <\/div>\n

\n “As a small company, we prefer working with smaller CROs where personal connections matter. It\u2019s about interacting directly with team members and having direct access to the CEO.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Rob Beathard<\/h6>\n

\n Chief Strategy Officer, jCyte <\/p>\n <\/div>\n <\/div>\n

\n “Working with this team has been a great experience thanks to their ‘white glove’ service and collaborative approach. We truly value their operational insights, which have helped us avoid potential issues as we work towards initiating our next trial. Their expertise and attention to detail has ensured a smoother process from the very start of our engagement.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Houman Hemmati, MD, PHD <\/h6>\n

\n Co-founder, Levation Pharma <\/p>\n <\/div>\n <\/div>\n

\n \u201cLexitas isn\u2019t a CRO \u2013 it\u2019s truly a partner committed to the success of each clinical program.\u201d <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Clare Guererro<\/h6>\n

\n Senior Director, Clinical Operations, PYC Therapeutics <\/p>\n <\/div>\n <\/div>\n

\n “We’ve had a wonderful experience working with Lexitas. Their dedication to excellence and seamless collaboration has made them an invaluable partner. Their expertise and commitment to our Quokka trial have consistently delivered outstanding results. We couldn’t ask for a better vendor to support our observational trial and research efforts.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Madhu Cherukury<\/h6>\n

\n Chief Executive Officer, Allgenesis <\/p>\n <\/div>\n <\/div>\n

\n “The Lexitas team has been a pleasure to work with, providing exceptional support throughout our clinical program, and providing an enjoyable collaborative effort in writing the CSR.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Justin Hanes<\/h6>\n

\n Chief Executive Officer, Novus Vision <\/p>\n <\/div>\n <\/div>\n

\n It has been a pleasure working with Lexitas. Their expertise in ophthalmology, attention to detail, and commitment to timelines made a complex process manageable and collaborative. Their proactive communication and problem-solving approach gave us confidence at every stage, and ultimately helped ensure the study ran smoothly from start to finish. <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Sean McDonald<\/h6>\n

\n Chief Executive Officer, Ocugenix <\/p>\n <\/div>\n <\/div>\n

\n “We chose Lexitas because of their exceptional experience in the ophthalmology field, with established relationships with key opinion leaders and clinical sites. Their expert management of our study will enable us to move ahead with our clinical development plan.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Sonja Krosser<\/h6>\n

\n VP Preclinical & Clinical Development, Novaliq <\/p>\n <\/div>\n <\/div>\n

\n “We value Lexitas as a full-service CRO that shares our passion for ophthalmology and our mission to bring innovative eye care treatments to patients. In our current project, Lexitas exceeded expectations by delivering the last patient-in well ahead of schedule.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
David Esposito<\/h6>\n

\n Chief Executive Officer, ONL Therapeutics <\/p>\n <\/div>\n <\/div>\n

\n “Lexitas was an instrumental partner in our study, delivering CRO services as well as access to their integrated Reading Center. With an exclusive focus on ophthalmology, their team was equipped to provide expert guidance and support throughout the project.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Ben Yerxa<\/h6>\n

\n Chief Executive Officer, Opus Genetics <\/p>\n <\/div>\n <\/div>\n

\n “As a small company, we prefer working with smaller CROs where personal connections matter. It\u2019s about interacting directly with team members and having direct access to the CEO.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Rob Beathard<\/h6>\n

\n Chief Strategy Officer, jCyte <\/p>\n <\/div>\n <\/div>\n

\n “Working with this team has been a great experience thanks to their ‘white glove’ service and collaborative approach. We truly value their operational insights, which have helped us avoid potential issues as we work towards initiating our next trial. Their expertise and attention to detail has ensured a smoother process from the very start of our engagement.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Houman Hemmati, MD, PHD <\/h6>\n

\n Co-founder, Levation Pharma <\/p>\n <\/div>\n <\/div>\n

\n \u201cLexitas isn\u2019t a CRO \u2013 it\u2019s truly a partner committed to the success of each clinical program.\u201d <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Clare Guererro<\/h6>\n

\n Senior Director, Clinical Operations, PYC Therapeutics <\/p>\n <\/div>\n <\/div>\n

\n “We’ve had a wonderful experience working with Lexitas. Their dedication to excellence and seamless collaboration has made them an invaluable partner. Their expertise and commitment to our Quokka trial have consistently delivered outstanding results. We couldn’t ask for a better vendor to support our observational trial and research efforts.” <\/div>\n <\/div>\n <\/div>\n
\n
\n
\n
\n
Madhu Cherukury<\/h6>\n

\n Chief Executive Officer, Allgenesis <\/p>\n <\/div>\n <\/div>\n

\n “The Lexitas team has been a pleasure to work with, providing exceptional support throughout our clinical program, and providing an enjoyable collaborative effort in writing the CSR.” <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n\n\n
\n
\n
\n
\n
\n \"\"\n

Partner with Lexitas for unparalleled expertise in ophthalmic clinical trials, ensuring timely and successful outcomes tailored to your study\u2019s unique needs.<\/h2>\n
\n \n Contact Us \n \n \n \n \n \n \n <\/linearGradient>\n <\/defs>\n<\/svg> <\/a>\n <\/div>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Lexitas is your partner for ophthalmic clinical research at every stage.<\/p>\n","protected":false},"author":18,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":true,"content-type":"","inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-27","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/lexitas.com\/wp-json\/wp\/v2\/pages\/27","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lexitas.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lexitas.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lexitas.com\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/lexitas.com\/wp-json\/wp\/v2\/comments?post=27"}],"version-history":[{"count":0,"href":"https:\/\/lexitas.com\/wp-json\/wp\/v2\/pages\/27\/revisions"}],"wp:attachment":[{"href":"https:\/\/lexitas.com\/wp-json\/wp\/v2\/media?parent=27"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}